Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Every January, millions of people start the new year vowing to lose weight. But in 2025, many of those hoping to shed the ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

The study used the company's older GLP-1 agonist therapy Saxenda (liraglutide), which requires a daily injection, rather than its top-selling once-weekly obesity drug Wegovy (semaglutide), and ...

The US is suffering an obesity epidemic: more than 1 in 3 adults (nearly 80 million) are obese, but can Saxenda really make a dent in this problem? Trial data showed that for a daily injection ...

The weekly injection helped overweight people drop ... It works in a similar way to Wegovy and Saxenda, but is more effective. Dr Mitra Dutt from LloydsPharmacy says: “Based on clinical trials ...

Like Ozempic and Saxenda, some doctors may prescribe this ... A person must take Mounjaro via a weekly injection. PlushCare healthcare professionals may request lab tests as part of the evaluation ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

An RTÉ Investigates undercover colleague messaged her, and she responded immediately, saying “I have Saxenda injection pens. Same as Ozempic. One pen lasts 18 days and the price is 100 euros.” ...

Professor Kamila Hawthorne, chairman of the Royal College of GPs, said she had 'serious concerns' about drugs sold by ...